VD

Vidyakant Dwivedi

Director Director DIN 09557282
DIN 09557282 First appointment Mar 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Vidyakant Dwivedi

Data last updated:

Vidyakant Dwivedi was a Director at Suncross Pharmaceuticals Private Limited (2023–2025) and Director at Feminore Healthcare Private Limited (2022). The companies operate in Pharma and Healthcare.

DIN 09557282
Primary Designation Director
Industry Pharma
First Appointment 31 Mar 2022

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 May 20232023₹14.9 Lakh (FY 2025)Active
Feminore Healthcare Private Limited U51909MP2022PTC060191
Director31 Mar 20222022₹21.6 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Suncross Pharmaceuticals Private Limited
Feminore Healthcare Private Limited
Premium access

Shareholding and investment profile for Vidyakant Dwivedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vidyakant Dwivedi

Vidyakant Dwivedi was first appointed on 31 Mar 2022 as Director at Feminore Healthcare Private Limited. The most recent appointment on record is 29 May 2023 at Suncross Pharmaceuticals Private Limited.

Vidyakant Dwivedi held 2 earlier board appointments: Suncross Pharmaceuticals Private Limited (Director, 29 May 2023 to 28 Aug 2025); Feminore Healthcare Private Limited (Director, 31 Mar 2022 to 20 Sep 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available